Abstract
Background: Both growth and survival of motor neurons may depend on multiple neurotrophic factors. Individually, insulin-like growth factor I (IGF-I) and glial cell line-derived neurotrophic factor (GDNF) are potent neurotrophic/survival factors for postnatal motor neurons. Methods: We used an organotypic spinal cord model of glutamatergic degeneration in ALS to investigate whether IGF-I and GDNF interact to enhance motor neuron survival, their trophic effect on choline acetyltransferase (ChAT) activity, and their effect on neurite outgrowth. Results: We show that the combination of IGF-I and GDNF at active doses (1) is additively neuroprotective, (2) completely rescues rat motor neurons from chronic glutamate-mediated toxicity, and (3) additively upregulates motor neuron ChAT activity. Further, IGF-I, which by itself does not promote neurite outgrowth in this model, potentiates the neurite promoting action of GDNF. Conclusion: The results predict that IGF-I combined with GDNF may provide a better therapy for the treatment of motor neuron disorders such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy.
Original language | English (US) |
---|---|
Pages (from-to) | 83-91 |
Number of pages | 9 |
Journal | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders |
Volume | 2 |
Issue number | 2 |
DOIs | |
State | Published - 2001 |
Keywords
- ALS
- Glutamate
- Neurotrophic factors
- Spinal cord
- Synergy
ASJC Scopus subject areas
- Clinical Neurology